Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News IQVIA Holdings Inc IQV

Healthcare Biotechnology
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment... see more

Recent & Breaking News (NYSE:IQV)

IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

Business Wire 3 days ago

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

Business Wire March 16, 2026

IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference

Business Wire March 2, 2026

IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference

Business Wire March 2, 2026

IQVIA Releases its 2025 Sustainability Report

Business Wire February 27, 2026

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

Business Wire February 25, 2026

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

Business Wire February 18, 2026

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

Business Wire February 10, 2026

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Business Wire February 5, 2026

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

Business Wire January 29, 2026

IQVIA Named to the Fortune® World's Most Admired Companies(TM) List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

Business Wire January 22, 2026

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

Business Wire January 20, 2026

IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

Business Wire December 2, 2025

Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

Business Wire November 5, 2025

IQVIA Reports Third-Quarter 2025 Results

Business Wire October 28, 2025

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025

Business Wire October 21, 2025

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

Business Wire September 30, 2025

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

Business Wire September 16, 2025

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

Business Wire September 10, 2025

IQVIA Announces CFO Transition in Early 2026

Business Wire September 2, 2025

Podcasts